{"id":2678,"date":"2026-08-24T08:21:45","date_gmt":"2026-08-24T08:21:45","guid":{"rendered":"https:\/\/uygarmicoogullari.com.tr\/2026\/08\/24\/ureter-tasi-tikanikligi-tedavisi\/"},"modified":"2026-08-24T08:21:45","modified_gmt":"2026-08-24T08:21:45","slug":"ureter-tasi-tikanikligi-tedavisi","status":"publish","type":"post","link":"https:\/\/uygarmicoogullari.com.tr\/en\/2026\/08\/24\/ureter-tasi-tikanikligi-tedavisi\/","title":{"rendered":"\u00dcreter Ta\u015f\u0131 T\u0131kan\u0131kl\u0131\u011f\u0131 Tedavisi Nas\u0131l Planlan\u0131r?"},"content":{"rendered":"

Belden ba\u015flay\u0131p kas\u0131\u011fa, testise veya genital b\u00f6lgeye yay\u0131lan \u015fiddetli a\u011fr\u0131 \u00e7o\u011fu zaman \u00fcreter ta\u015f\u0131n\u0131n ilk belirgin i\u015faretidir. Ancak as\u0131l mesele yaln\u0131zca a\u011fr\u0131 de\u011fildir: Ta\u015f, b\u00f6brekten mesaneye idrar ta\u015f\u0131yan \u00fcreteri t\u0131kad\u0131\u011f\u0131nda idrar\u0131n b\u00f6brekte birikmesine ve b\u00f6brek bas\u0131nc\u0131n\u0131n artmas\u0131na yol a\u00e7abilir. Bu nedenle \u00fcreter ta\u015f\u0131 t\u0131kan\u0131kl\u0131\u011f\u0131 tedavisi<\/strong>, a\u011fr\u0131y\u0131 bast\u0131rman\u0131n \u00f6tesinde, b\u00f6brek fonksiyonunu korumay\u0131 ve enfeksiyon riskini g\u00fcvenle y\u00f6netmeyi hedefler.<\/p>\n

Her ta\u015f ayn\u0131 \u015fekilde davranmaz. Baz\u0131 k\u00fc\u00e7\u00fck ta\u015flar uygun takip alt\u0131nda kendili\u011finden d\u00fc\u015febilirken, baz\u0131lar\u0131 boyutu k\u00fc\u00e7\u00fck olsa dahi \u00fcreterin dar bir b\u00f6l\u00fcm\u00fcne yerle\u015ferek ciddi a\u011fr\u0131, tekrarlayan acil ba\u015fvurusu veya b\u00f6brekte geni\u015fleme olu\u015fturabilir. Tedavi karar\u0131, tek bir g\u00f6r\u00fcnt\u00fcleme sonucuna de\u011fil; ta\u015f\u0131n \u00f6zelliklerine, hastan\u0131n klinik durumuna ve b\u00f6bre\u011fin etkilenme d\u00fczeyine birlikte bak\u0131larak verilmelidir.<\/p>\n

\u00dcreter ta\u015f\u0131 t\u0131kan\u0131kl\u0131\u011f\u0131 neden \u00f6nemlidir?<\/h2>\n

\u00dcreter, b\u00f6brekten gelen idrar\u0131n mesaneye ula\u015ft\u0131\u011f\u0131 ince bir kanald\u0131r. Ta\u015f bu kanal\u0131 k\u0131smen ya da tamamen kapatt\u0131\u011f\u0131nda b\u00f6brek i\u00e7indeki bas\u0131n\u00e7 artar. G\u00f6r\u00fcnt\u00fclemelerde hidronefroz olarak ifade edilen b\u00f6brek geni\u015flemesi geli\u015febilir. T\u0131kan\u0131kl\u0131k uzun s\u00fcrerse, \u00f6zellikle mevcut b\u00f6brek hastal\u0131\u011f\u0131 bulunan ki\u015filerde fonksiyon kayb\u0131 riski artabilir.<\/p>\n

En kritik tablo, t\u0131kan\u0131kl\u0131\u011fa enfeksiyonun e\u015flik etmesidir. Ate\u015f, titreme, halsizlik, bulant\u0131-kusma ve idrar yaparken yanma<\/a> gibi bulgular varsa, enfekte t\u0131kal\u0131 b\u00f6brek olas\u0131l\u0131\u011f\u0131 h\u0131zla de\u011ferlendirilmelidir. Bu durum yaln\u0131zca ta\u015f d\u00fc\u015f\u00fcrme beklentisiyle evde izlenmemelidir; kana kar\u0131\u015fan enfeksiyon ciddi sonu\u00e7lara neden olabilir.<\/p>\n

Tek b\u00f6bre\u011fi olan hastalarda, her iki \u00fcreterde t\u0131kan\u0131kl\u0131k saptand\u0131\u011f\u0131nda veya b\u00f6brek fonksiyon testlerinde bozulma g\u00f6r\u00fcld\u00fc\u011f\u00fcnde de yakla\u015f\u0131m daha acil olur. A\u011fr\u0131n\u0131n ila\u00e7larla kontrol alt\u0131na al\u0131namamas\u0131 ve s\u00fcrekli kusma nedeniyle s\u0131v\u0131 al\u0131namamas\u0131 da erken giri\u015fim gerektirebilir.<\/p>\n

Tan\u0131da hangi bilgiler tedaviyi de\u011fi\u015ftirir?<\/h2>\n

\u00dcreter ta\u015f\u0131 \u015f\u00fcphesi olan hastada muayene, idrar tahlili, b\u00f6brek fonksiyon testleri ve g\u00f6r\u00fcnt\u00fcleme birlikte de\u011ferlendirilir. \u0130drar tahlili kanama veya enfeksiyon bulgular\u0131n\u0131 g\u00f6sterebilir. Gerekti\u011finde idrar k\u00fclt\u00fcr\u00fc al\u0131narak enfeksiyonun etkeni belirlenir.<\/p>\n

Ta\u015f hastal\u0131\u011f\u0131nda<\/a> \u00e7o\u011fu zaman kontrasts\u0131z bilgisayarl\u0131 tomografi, ta\u015f\u0131n boyutunu, bulundu\u011fu seviyeyi ve t\u0131kan\u0131kl\u0131\u011f\u0131n derecesini ayr\u0131nt\u0131l\u0131 bi\u00e7imde ortaya koyar. Ultrasonografi ise b\u00f6brekte geni\u015flemeyi de\u011ferlendirmede ve takipte de\u011ferli bir y\u00f6ntemdir. Her hastaya ayn\u0131 g\u00f6r\u00fcnt\u00fcleme yakla\u015f\u0131m\u0131 uygulanmaz; gebelik, b\u00f6brek fonksiyonu, \u00f6nceki tetkikler ve klinik gereksinim g\u00f6z \u00f6n\u00fcnde bulundurulur.<\/p>\n

Tedaviyi en \u00e7ok etkileyen ayr\u0131nt\u0131lar ta\u015f\u0131n milimetrik boyutu, \u00fcreterin \u00fcst, orta veya alt b\u00f6l\u00fcm\u00fcndeki yeri, ta\u015f yo\u011funlu\u011fu, b\u00f6brekteki geni\u015fleme ve hastan\u0131n a\u011fr\u0131-enfeksiyon durumudur. \u00d6rne\u011fin alt \u00fcreterdeki k\u00fc\u00e7\u00fck bir ta\u015f\u0131n d\u00fc\u015fme olas\u0131l\u0131\u011f\u0131, \u00fcst \u00fcreterdeki daha b\u00fcy\u00fck bir ta\u015fla ayn\u0131 de\u011fildir. Bu y\u00fczden yaln\u0131zca \u201cta\u015f ka\u00e7 milimetre?\u201d sorusuyla karar vermek yeterli olmaz.<\/p>\n

\u00dcreter ta\u015f\u0131 t\u0131kan\u0131kl\u0131\u011f\u0131 tedavisi se\u00e7enekleri<\/h2>\n

Uygun hastada takip ve medikal yakla\u015f\u0131m<\/h3>\n

K\u00fc\u00e7\u00fck boyutlu, enfeksiyonsuz, b\u00f6brek fonksiyonunu tehdit etmeyen ve a\u011fr\u0131s\u0131 kontrol alt\u0131nda olan ta\u015flarda belirli bir s\u00fcre takip planlanabilir. Bu s\u00fcre\u00e7te a\u011fr\u0131 tedavisi, hastaya uygun s\u0131v\u0131 d\u00fczeni ve baz\u0131 olgularda ta\u015f\u0131n ilerlemesini desteklemeyi ama\u00e7layan ila\u00e7lar kullan\u0131labilir. \u0130la\u00e7 se\u00e7imi; tansiyon, kalp-damar hastal\u0131\u011f\u0131, kullan\u0131lan di\u011fer ila\u00e7lar ve yan etki riski dikkate al\u0131narak hekim taraf\u0131ndan yap\u0131lmal\u0131d\u0131r.<\/p>\n

Takip, \u201cbeklemek\u201d anlam\u0131na gelmez. A\u011fr\u0131 ataklar\u0131n\u0131n s\u0131kl\u0131\u011f\u0131, ate\u015f geli\u015fimi, idrar miktar\u0131, b\u00f6brek fonksiyonlar\u0131 ve kontrol g\u00f6r\u00fcnt\u00fclemeleri d\u00fczenli olarak de\u011ferlendirilir. Ta\u015f ilerlemiyorsa, t\u0131kan\u0131kl\u0131k s\u00fcr\u00fcyorsa veya ya\u015fam kalitesini belirgin bi\u00e7imde bozuyorsa tedavi plan\u0131 de\u011fi\u015ftirilir.<\/p>\n

Halk aras\u0131nda yayg\u0131n olan a\u015f\u0131r\u0131 su i\u00e7menin her ta\u015f\u0131 d\u00fc\u015f\u00fcrece\u011fi d\u00fc\u015f\u00fcncesi do\u011fru de\u011fildir. \u00d6zellikle tam t\u0131kan\u0131kl\u0131k ve \u015fiddetli a\u011fr\u0131 varken kontrols\u00fcz s\u0131v\u0131 t\u00fcketimi a\u011fr\u0131y\u0131 art\u0131rabilir. S\u0131v\u0131 al\u0131m\u0131, hastan\u0131n kusma durumu ve t\u0131kan\u0131kl\u0131\u011f\u0131n derecesiyle birlikte de\u011ferlendirilmelidir.<\/p>\n

Acil drenaj: \u00d6nce b\u00f6bre\u011fi g\u00fcvene almak<\/h3>\n

Ate\u015fli enfeksiyonla birlikte t\u0131kan\u0131kl\u0131k, b\u00f6brek fonksiyonunda h\u0131zl\u0131 bozulma veya kontrol edilemeyen a\u011fr\u0131 varsa \u00f6ncelik ta\u015f\u0131 ayn\u0131 seansta k\u0131rmak olmayabilir. \u0130lk hedef, b\u00f6brekte biriken idrar\u0131 bo\u015faltarak bas\u0131nc\u0131 azaltmak ve enfeksiyonu kontrol alt\u0131na almakt\u0131r.<\/p>\n

Bu ama\u00e7la \u00fcreter i\u00e7ine \u00e7ift J stent yerle\u015ftirilebilir veya baz\u0131 durumlarda ciltten b\u00f6bre\u011fe uzanan nefrostomi kateteri uygulanabilir. Hangi y\u00f6ntemin se\u00e7ilece\u011fi ta\u015f\u0131n konumu, enfeksiyonun \u015fiddeti, anatomik ko\u015fullar ve hastan\u0131n genel durumu ile belirlenir. Enfeksiyon kontrol alt\u0131na al\u0131nd\u0131ktan sonra ta\u015f\u0131n kesin tedavisi planlan\u0131r.<\/p>\n

\u00c7ift J stent, hastay\u0131 ta\u015f hastal\u0131\u011f\u0131ndan tamamen kurtaran bir i\u015flem de\u011fildir; b\u00f6bre\u011fin drenaj\u0131n\u0131 sa\u011flayan ge\u00e7ici bir \u00e7\u00f6z\u00fcmd\u00fcr. Stent varken s\u0131k idrara \u00e7\u0131kma, idrarda yanma, hareketle bel-kas\u0131k a\u011fr\u0131s\u0131 veya idrarda hafif kanama g\u00f6r\u00fclebilir. Bu \u015fikayetler \u00e7o\u011fu hastada y\u00f6netilebilir d\u00fczeydedir, ancak stentin ne zaman \u00e7\u0131kar\u0131laca\u011f\u0131 mutlaka takip edilmelidir.<\/p>\n

Lazerli kapal\u0131 \u00fcreter ta\u015f\u0131 cerrahisi: URS<\/h3>\n

\u00dcreteroskopi, yani URS, \u00fcretra ve mesane yoluyla \u00fcretere ince endoskopik cihazlarla girilerek ta\u015f\u0131n do\u011frudan g\u00f6r\u00fclmesini sa\u011flar. Ciltte kesi yap\u0131lmadan ger\u00e7ekle\u015ftirilen bu y\u00f6ntemde ta\u015f, lazer enerjisiyle k\u00fc\u00e7\u00fck par\u00e7alara ayr\u0131labilir ve uygun par\u00e7alar \u00e7\u0131kar\u0131labilir. \u00d6zellikle d\u00fc\u015fme olas\u0131l\u0131\u011f\u0131 d\u00fc\u015f\u00fck olan, a\u011fr\u0131 veya t\u0131kan\u0131kl\u0131k olu\u015fturan \u00fcreter ta\u015flar\u0131nda etkili bir se\u00e7enektir.<\/p>\n

URS s\u0131ras\u0131nda her ta\u015f\u0131n tamamen tek par\u00e7a halinde al\u0131nmas\u0131 hedeflenmez. Ta\u015f\u0131n sertli\u011fi, yerle\u015fimi, \u00fcreterin yap\u0131s\u0131 ve g\u00fcvenli ilerleme ko\u015fullar\u0131 i\u015flemin stratejisini belirler. Baz\u0131 hastalarda i\u015flem sonunda ge\u00e7ici stent kullan\u0131lmas\u0131, \u00fcreterdeki \u00f6demin azalmas\u0131na ve idrar ak\u0131m\u0131n\u0131n korunmas\u0131na yard\u0131mc\u0131 olur.<\/p>\n

Lazerli kapal\u0131 cerrahinin \u00f6nemli avantajlar\u0131, a\u00e7\u0131k ameliyat kesisi gerektirmemesi ve \u00e7o\u011fu hastada g\u00fcnl\u00fck ya\u015fama daha k\u0131sa s\u00fcrede d\u00f6n\u00fc\u015f sa\u011flamas\u0131d\u0131r. Bununla birlikte her cerrahi giri\u015fimde oldu\u011fu gibi enfeksiyon, kanama, stent ili\u015fkili yak\u0131nmalar, ta\u015f par\u00e7as\u0131 kalmas\u0131 veya nadiren \u00fcreter yaralanmas\u0131 gibi riskler vard\u0131r. Bu riskler i\u015flem \u00f6ncesinde a\u00e7\u0131k bi\u00e7imde konu\u015fulmal\u0131, hastaya ger\u00e7ek\u00e7i beklenti sunulmal\u0131d\u0131r.<\/p>\n

Ta\u015f\u0131n yerine g\u00f6re di\u011fer y\u00f6ntemler<\/h3>\n

\u015eok dalga tedavisi olarak bilinen ESWL, se\u00e7ilmi\u015f baz\u0131 \u00fcreter ta\u015flar\u0131nda d\u0131\u015far\u0131dan uygulanan ses dalgalar\u0131yla ta\u015f\u0131 par\u00e7alamay\u0131 ama\u00e7lar. Ta\u015f\u0131n yo\u011funlu\u011fu, boyutu, konumu ve hastan\u0131n v\u00fccut yap\u0131s\u0131 bu y\u00f6ntemin ba\u015far\u0131 olas\u0131l\u0131\u011f\u0131n\u0131 etkiler. Baz\u0131 ta\u015flarda birden fazla seans gerekebilir ve par\u00e7alar\u0131n sonras\u0131nda d\u00fc\u015fmesi beklenir.<\/p>\n

Ta\u015f\u0131n b\u00f6bre\u011fe uzanmas\u0131, b\u00fcy\u00fck hacimli e\u015flik eden b\u00f6brek ta\u015flar\u0131 veya karma\u015f\u0131k anatomik durumlarda RIRS ya da PNL<\/a> gibi ileri kapal\u0131 ta\u015f cerrahisi teknikleri g\u00fcndeme gelebilir. En do\u011fru y\u00f6ntem, en yeni teknolojinin rutin olarak uygulanmas\u0131 de\u011fil, o hasta i\u00e7in en g\u00fcvenli ve en y\u00fcksek ba\u015far\u0131 olas\u0131l\u0131\u011f\u0131 ta\u015f\u0131yan yakla\u015f\u0131m\u0131n se\u00e7ilmesidir.<\/p>\n

Ameliyat sonras\u0131 s\u00fcre\u00e7te nelere dikkat edilir?<\/h2>\n

Lazerli \u00fcreter ta\u015f\u0131 cerrahisi sonras\u0131nda k\u0131sa s\u00fcreli yanma, s\u0131k idrara \u00e7\u0131kma ve idrarda hafif pembe renk g\u00f6r\u00fclebilir. Stent varsa bu yak\u0131nmalar daha belirgin hissedilebilir. Hekimin \u00f6nerdi\u011fi ila\u00e7lar\u0131n d\u00fczenli kullan\u0131lmas\u0131, planlanan kontrol\u00fcn aksat\u0131lmamas\u0131 ve stent \u00e7\u0131karma tarihinin takip edilmesi \u00f6nemlidir.<\/p>\n

38 derece ve \u00fczeri ate\u015f, titreme, giderek artan \u015fiddetli a\u011fr\u0131, idrar yapamama, yo\u011fun kanama veya durmayan kusma geli\u015firse gecikmeden sa\u011fl\u0131k kurulu\u015funa ba\u015fvurulmal\u0131d\u0131r. Bu belirtiler, basit bir ameliyat sonras\u0131 rahats\u0131zl\u0131ktan farkl\u0131 olarak enfeksiyon veya drenaj sorunu d\u00fc\u015f\u00fcnd\u00fcrebilir.<\/p>\n

Ta\u015f \u00e7\u0131kar\u0131ld\u0131ktan sonra s\u00fcre\u00e7 bitmi\u015f say\u0131lmaz. Tekrarlayan ta\u015f hastal\u0131\u011f\u0131nda ta\u015f analizi, kan ve idrar incelemeleri ile metabolik de\u011ferlendirme yap\u0131labilir. Yetersiz s\u0131v\u0131 al\u0131m\u0131, fazla tuz t\u00fcketimi, y\u00fcksek hayvansal protein al\u0131m\u0131, baz\u0131 metabolik hastal\u0131klar ve ailesel yatk\u0131nl\u0131k ta\u015f olu\u015fumunu etkileyebilir. Koruyucu plan, ta\u015f\u0131n t\u00fcr\u00fcne ve ki\u015finin ya\u015fam d\u00fczenine g\u00f6re haz\u0131rlanmal\u0131d\u0131r.<\/p>\n

Ki\u015fiye \u00f6zel planlama neden fark yarat\u0131r?<\/h2>\n

\u00dcreter ta\u015f\u0131 tedavisinde hedef yaln\u0131zca g\u00f6r\u00fcnt\u00fclemede ta\u015f\u0131 ortadan kald\u0131rmak de\u011fildir. B\u00f6bre\u011fin korunmas\u0131, a\u011fr\u0131n\u0131n g\u00fcvenle y\u00f6netilmesi, enfeksiyonun atlanmamas\u0131, gereksiz giri\u015fimden ka\u00e7\u0131n\u0131lmas\u0131 ve ta\u015f\u0131n tekrar\u0131n\u0131 azaltacak \u00f6nlemlerin al\u0131nmas\u0131 ayn\u0131 plan\u0131n par\u00e7alar\u0131d\u0131r.<\/p>\n

Do\u00e7. Dr. Uygar Mi\u00e7oo\u011fullar\u0131\u2019n\u0131n yakla\u015f\u0131m\u0131nda, kapal\u0131 ve lazerli ta\u015f cerrahisi se\u00e7enekleri ayr\u0131nt\u0131l\u0131 de\u011ferlendirme ile hastaya \u00f6zel planlan\u0131r; i\u015flem \u00f6ncesi bilgilendirme ve i\u015flem sonras\u0131 yak\u0131n takip tedavinin devam\u0131 olarak g\u00f6r\u00fcl\u00fcr. Bel ve kas\u0131k a\u011fr\u0131s\u0131na ate\u015f, kusma veya idrar yapmada belirgin azalma e\u015flik ediyorsa, ta\u015f\u0131n kendili\u011finden d\u00fc\u015fmesini beklemek yerine zaman\u0131nda \u00fcroloji de\u011ferlendirmesi almak b\u00f6bre\u011finizi koruyan en do\u011fru ad\u0131m olabilir.<\/p>","protected":false},"excerpt":{"rendered":"

\u00dcreter ta\u015f\u0131 t\u0131kan\u0131kl\u0131\u011f\u0131 tedavisi; a\u011fr\u0131n\u0131n kontrol\u00fc, b\u00f6brek fonksiyonunun korunmas\u0131 ve ta\u015f\u0131n uygun y\u00f6ntemle \u00e7\u0131kar\u0131lmas\u0131 i\u00e7in bireye \u00f6zel planlan\u0131r.<\/p>","protected":false},"author":0,"featured_media":2679,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-2678","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/uygarmicoogullari.com.tr\/en\/wp-json\/wp\/v2\/posts\/2678","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/uygarmicoogullari.com.tr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/uygarmicoogullari.com.tr\/en\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/uygarmicoogullari.com.tr\/en\/wp-json\/wp\/v2\/comments?post=2678"}],"version-history":[{"count":0,"href":"https:\/\/uygarmicoogullari.com.tr\/en\/wp-json\/wp\/v2\/posts\/2678\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/uygarmicoogullari.com.tr\/en\/wp-json\/wp\/v2\/media\/2679"}],"wp:attachment":[{"href":"https:\/\/uygarmicoogullari.com.tr\/en\/wp-json\/wp\/v2\/media?parent=2678"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/uygarmicoogullari.com.tr\/en\/wp-json\/wp\/v2\/categories?post=2678"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/uygarmicoogullari.com.tr\/en\/wp-json\/wp\/v2\/tags?post=2678"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}